-
1
-
-
5044228670
-
Analyses of nursing home residents with diabetes at admission
-
Travis S.S., Buchanan R.J., Wang S., et al. Analyses of nursing home residents with diabetes at admission. J Am Med Dir Assoc 5 (2004) 320-327
-
(2004)
J Am Med Dir Assoc
, vol.5
, pp. 320-327
-
-
Travis, S.S.1
Buchanan, R.J.2
Wang, S.3
-
2
-
-
28744436260
-
Comorbidities among Ohio's nursing home residents with diabetes
-
Duffy R.E., Mattson B.J., and Zack M. Comorbidities among Ohio's nursing home residents with diabetes. J Am Med Dir Assoc 6 (2005) 383-389
-
(2005)
J Am Med Dir Assoc
, vol.6
, pp. 383-389
-
-
Duffy, R.E.1
Mattson, B.J.2
Zack, M.3
-
3
-
-
21544460165
-
Hospitalizations, nursing home admissions, and deaths attributable to diabetes
-
Russell L.B., Valiyeva E., Roman S.H., et al. Hospitalizations, nursing home admissions, and deaths attributable to diabetes. Diabetes Care 28 (2005) 1611-1617
-
(2005)
Diabetes Care
, vol.28
, pp. 1611-1617
-
-
Russell, L.B.1
Valiyeva, E.2
Roman, S.H.3
-
4
-
-
35148870802
-
Diabetes and long-term care
-
Harris M.I., Cowie C.C., Stern M.P., et al. (Eds), National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
-
Mayfield J.A., Deb P., and Potter D.E.B. Diabetes and long-term care. In: Harris M.I., Cowie C.C., Stern M.P., et al. (Eds). Diabetes in America. 2nd ed. (2004), National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
-
(2004)
Diabetes in America. 2nd ed.
-
-
Mayfield, J.A.1
Deb, P.2
Potter, D.E.B.3
-
5
-
-
33845996154
-
Standards of medical care in diabetes-2007
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl 1 (2007) S4-S41
-
(2007)
Diabetes Care
, vol.30
, Issue.SUPPL. 1
-
-
-
6
-
-
35148872651
-
-
Centers for Disease Control and Prevention. Data & trends. National diabetes surveillance system. Prevalence of diabetes: Prevalence of diagnosed diabetes by age, United States, 1980-2005. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm. Accessed July 23, 2007.
-
-
-
-
7
-
-
2642626655
-
Economic consequences of diabetes mellitus in the U.S. in 1997
-
American Diabetes Association
-
American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21 (1998) 296-309
-
(1998)
Diabetes Care
, vol.21
, pp. 296-309
-
-
-
8
-
-
0043244907
-
Economic costs of diabetes in the U.S. in 2002
-
American Diabetes Association
-
American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26 (2003) 917-932
-
(2003)
Diabetes Care
, vol.26
, pp. 917-932
-
-
-
9
-
-
80051546846
-
Cost of glycemic control in long term care
-
Smith S.A., Cabanala R.L., Anderson S.S., et al. Cost of glycemic control in long term care. Diabetes 54 Suppl 1 (2006) A1-A733
-
(2006)
Diabetes
, vol.54
, Issue.SUPPL. 1
-
-
Smith, S.A.1
Cabanala, R.L.2
Anderson, S.S.3
-
10
-
-
33646260470
-
Medicare coverage for patients with diabetes. A national plan with individual consequences
-
Ashkenazy R., and Abrahamson M.J. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med 21 (2006) 386-392
-
(2006)
J Gen Intern Med
, vol.21
, pp. 386-392
-
-
Ashkenazy, R.1
Abrahamson, M.J.2
-
11
-
-
0032977099
-
Reported and measured physical functioning in older inner-city diabetic African Americans
-
Miller D.K., Lui L.-Y.L., Perry III H.M., et al. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol A Biol Sci Med Sci 54A (1999) M230-M236
-
(1999)
J Gerontol A Biol Sci Med Sci
, vol.54 A
-
-
Miller, D.K.1
Lui, L.-Y.L.2
Perry III, H.M.3
-
12
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton I.M., Adler A.I., Neil H.A.W., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
-
13
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393
-
(2003)
N Engl J Med
, vol.348
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
-
14
-
-
35148874614
-
Optimization of treatment of type 2 diabetes in the elderly
-
Available at: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621. Accessed July 23, 2007.
-
Konzem S.L. Optimization of treatment of type 2 diabetes in the elderly. US Pharmacist 25 (2000). http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621 Available at: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/SrConsu ltcfm.cfm&pub_id=8&article_id=621. Accessed July 23, 2007.
-
(2000)
US Pharmacist
, vol.25
-
-
Konzem, S.L.1
-
15
-
-
33947715412
-
Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: Outcome of a 6-year prospective study
-
Katakura M., Naka M., Kondo T., et al. Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: Outcome of a 6-year prospective study. Diabetes 54 Suppl 1 (2005) A733
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 1
-
-
Katakura, M.1
Naka, M.2
Kondo, T.3
-
16
-
-
0030775291
-
The cost to health plans of poor glycemic control
-
Gilmer T.P., O'Connor P.J., Manning W.G., et al. The cost to health plans of poor glycemic control. Diabetes Care 20 (1997) 1847-1853
-
(1997)
Diabetes Care
, vol.20
, pp. 1847-1853
-
-
Gilmer, T.P.1
O'Connor, P.J.2
Manning, W.G.3
-
17
-
-
11844298970
-
Predictors of health care costs in adults with diabetes
-
Gilmer T.P., O'Connor P.J., Rush W.A., et al. Predictors of health care costs in adults with diabetes. Diabetes Care 28 (2005) 59-64
-
(2005)
Diabetes Care
, vol.28
, pp. 59-64
-
-
Gilmer, T.P.1
O'Connor, P.J.2
Rush, W.A.3
-
18
-
-
33646384383
-
The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus
-
Zarowitz B.J., Tangalos E.G., Hollenack K., et al. The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus. J Am Med Dir Assoc 7 (2006) 234-240
-
(2006)
J Am Med Dir Assoc
, vol.7
, pp. 234-240
-
-
Zarowitz, B.J.1
Tangalos, E.G.2
Hollenack, K.3
-
19
-
-
25644444543
-
Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility
-
Maurer M.S., Burcham J., and Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 60 (2005) 1157-1162
-
(2005)
J Gerontol A Biol Sci Med Sci
, vol.60
, pp. 1157-1162
-
-
Maurer, M.S.1
Burcham, J.2
Cheng, H.3
-
20
-
-
0036062666
-
Low muscle mass of the thigh is significantly correlated with delirium and worse functional outcome in older medical patients
-
Weinrebe W., Güneysu S., and Welz-Barth A. Low muscle mass of the thigh is significantly correlated with delirium and worse functional outcome in older medical patients. J Am Geriatr Soc 50 (2002) 1310-1311
-
(2002)
J Am Geriatr Soc
, vol.50
, pp. 1310-1311
-
-
Weinrebe, W.1
Güneysu, S.2
Welz-Barth, A.3
-
21
-
-
33749462321
-
Is weight loss harmful to older men?
-
Morley J.E. Is weight loss harmful to older men?. Aging Male 9 (2006) 135-137
-
(2006)
Aging Male
, vol.9
, pp. 135-137
-
-
Morley, J.E.1
-
22
-
-
17644419677
-
Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents
-
Allsworth J.E., Toppa R., Palin N.C., et al. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis 15 (2005) 205-212
-
(2005)
Ethn Dis
, vol.15
, pp. 205-212
-
-
Allsworth, J.E.1
Toppa, R.2
Palin, N.C.3
-
23
-
-
35148875565
-
Diabetes management in the extended care setting
-
Shubrook J.H., and Gau J.-T. Diabetes management in the extended care setting. Diabetes 54 Suppl 1 (2006) 733
-
(2006)
Diabetes
, vol.54
, Issue.SUPPL. 1
, pp. 733
-
-
Shubrook, J.H.1
Gau, J.-T.2
-
24
-
-
2542435289
-
Diabetic foot care in a long-term facility
-
Berry R.M., and Hunt Raleigh E.D. Diabetic foot care in a long-term facility. J Gerontol Nurs 30 (2004) 8-13
-
(2004)
J Gerontol Nurs
, vol.30
, pp. 8-13
-
-
Berry, R.M.1
Hunt Raleigh, E.D.2
-
25
-
-
0035655133
-
The use of a no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes
-
Tariq S.H., Karcic E., Thomas D.R., et al. The use of a no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes. J Am Diet Assoc 101 (2001) 1463-1466
-
(2001)
J Am Diet Assoc
, vol.101
, pp. 1463-1466
-
-
Tariq, S.H.1
Karcic, E.2
Thomas, D.R.3
-
27
-
-
35148816545
-
-
US Pharmacopeia, USP Center for the Advancement of Patient Safety July
-
US Pharmacopeia. USP Patient Safety CAPSlink (2003), USP Center for the Advancement of Patient Safety July
-
(2003)
USP Patient Safety CAPSlink
-
-
-
28
-
-
0031004420
-
Diabetes in institutionalised elderly people: A forgotten population?
-
Benbow S.J., Walsh A., and Gill G.V. Diabetes in institutionalised elderly people: A forgotten population?. BMJ 314 (1997) 1868-1869
-
(1997)
BMJ
, vol.314
, pp. 1868-1869
-
-
Benbow, S.J.1
Walsh, A.2
Gill, G.V.3
-
29
-
-
0032926966
-
Pathophysiology of type 2 diabetes in the elderly
-
Meneilly G.S. Pathophysiology of type 2 diabetes in the elderly. Clin Geriatr Med 15 (1999) 239-253
-
(1999)
Clin Geriatr Med
, vol.15
, pp. 239-253
-
-
Meneilly, G.S.1
-
30
-
-
0037968349
-
Guidelines for improving the care of the older person with diabetes mellitus
-
California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes
-
California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51 Suppl 5 (2003) S265-S280
-
(2003)
J Am Geriatr Soc
, vol.51
, Issue.SUPPL. 5
-
-
-
31
-
-
18644375984
-
Mood and cognitive function in elderly diabetic patients living in care facilities
-
Hagemann R., Sartory G., Hader C., et al. Mood and cognitive function in elderly diabetic patients living in care facilities. Dement Geriatr Cogn Disord 19 (2005) 369-375
-
(2005)
Dement Geriatr Cogn Disord
, vol.19
, pp. 369-375
-
-
Hagemann, R.1
Sartory, G.2
Hader, C.3
-
32
-
-
17244369031
-
Management of diabetes mellitus medications in the nursing home
-
Haas L. Management of diabetes mellitus medications in the nursing home. Drugs Aging 22 (2005) 209-218
-
(2005)
Drugs Aging
, vol.22
, pp. 209-218
-
-
Haas, L.1
-
33
-
-
20444437249
-
Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: What are we waiting for?
-
Gaede P., and Pedersen O. Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: What are we waiting for?. Horm Metab Res 37 Suppl 1 (2005) 76-82
-
(2005)
Horm Metab Res
, vol.37
, Issue.SUPPL. 1
, pp. 76-82
-
-
Gaede, P.1
Pedersen, O.2
-
34
-
-
0032983666
-
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49)
-
Turner R.C., Cull C.A., Frighi V., et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 281 (1999) 2005-2012
-
(1999)
JAMA
, vol.281
, pp. 2005-2012
-
-
Turner, R.C.1
Cull, C.A.2
Frighi, V.3
-
35
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
36
-
-
0030842472
-
Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited
-
Cleveland Jr. J.C., Meldrum D.R., Cain B.S., et al. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 96 (1997) 29-32
-
(1997)
Circulation
, vol.96
, pp. 29-32
-
-
Cleveland Jr., J.C.1
Meldrum, D.R.2
Cain, B.S.3
-
37
-
-
0033377296
-
The use of sulphonylureas in the elderly
-
Graal M.B., and Wolffenbuttel B.H.R. The use of sulphonylureas in the elderly. Drugs Aging 15 (1999) 471-481
-
(1999)
Drugs Aging
, vol.15
, pp. 471-481
-
-
Graal, M.B.1
Wolffenbuttel, B.H.R.2
-
38
-
-
31544473434
-
Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group
-
Sakharova O.V., and Inzucchi S.E. Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group. Postgrad Med 118 (2005) 19-29
-
(2005)
Postgrad Med
, vol.118
, pp. 19-29
-
-
Sakharova, O.V.1
Inzucchi, S.E.2
-
39
-
-
0034002527
-
Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease
-
Krepinsky J., Ingram A.J., and Clase C.M. Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease. Am J Kidney Dis 35 (2000) 500-505
-
(2000)
Am J Kidney Dis
, vol.35
, pp. 500-505
-
-
Krepinsky, J.1
Ingram, A.J.2
Clase, C.M.3
-
40
-
-
0031614038
-
Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
-
Lee A., and Morley J.E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 6 (1998) 47-53
-
(1998)
Obes Res
, vol.6
, pp. 47-53
-
-
Lee, A.1
Morley, J.E.2
-
41
-
-
10744221639
-
Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association
-
Nesto R.W., Bell D., Bonow R.O., et al. Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 27 (2004) 256-263
-
(2004)
Diabetes Care
, vol.27
, pp. 256-263
-
-
Nesto, R.W.1
Bell, D.2
Bonow, R.O.3
-
42
-
-
0036708117
-
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics
-
Lee A., Patrick P., Wishart J., et al. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab 4 (2002) 329-335
-
(2002)
Diabetes Obes Metab
, vol.4
, pp. 329-335
-
-
Lee, A.1
Patrick, P.2
Wishart, J.3
-
43
-
-
0036183110
-
The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents
-
Rosak C. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents. J Diabetes Complications 16 (2002) 123-132
-
(2002)
J Diabetes Complications
, vol.16
, pp. 123-132
-
-
Rosak, C.1
-
44
-
-
33646806766
-
Toxicology of oral antidiabetic medications
-
Spiller H.A., and Sawyer T.S. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 63 (2006) 929-938
-
(2006)
Am J Health Syst Pharm
, vol.63
, pp. 929-938
-
-
Spiller, H.A.1
Sawyer, T.S.2
-
45
-
-
35148854086
-
-
[prescribing information], Merck & Co., Inc, Whitehouse Station, NJ
-
Januvia. [prescribing information] (2006), Merck & Co., Inc, Whitehouse Station, NJ
-
(2006)
Januvia
-
-
-
46
-
-
0029839173
-
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells
-
Kramer W., Müller G., and Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells. Horm Metab Res 28 (1996) 464-468
-
(1996)
Horm Metab Res
, vol.28
, pp. 464-468
-
-
Kramer, W.1
Müller, G.2
Geisen, K.3
-
47
-
-
9444284451
-
The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium
-
Quast U., Stephan D., Bieger S., et al. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 53 Suppl 3 (2004) S156-S164
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Quast, U.1
Stephan, D.2
Bieger, S.3
-
48
-
-
0035954260
-
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide
-
Mocanu M.M., Maddock H.L., Baxter G.F., et al. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation 103 (2001) 3111-3116
-
(2001)
Circulation
, vol.103
, pp. 3111-3116
-
-
Mocanu, M.M.1
Maddock, H.L.2
Baxter, G.F.3
-
49
-
-
0031972156
-
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group
-
Matthews D.R., Cull C.A., Stratton I.M., et al. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15 (1998) 297-303
-
(1998)
Diabet Med
, vol.15
, pp. 297-303
-
-
Matthews, D.R.1
Cull, C.A.2
Stratton, I.M.3
-
50
-
-
18144377715
-
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes
-
Cook M.N., Girman C.J., Stein P.P., et al. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care 28 (2005) 995-1000
-
(2005)
Diabetes Care
, vol.28
, pp. 995-1000
-
-
Cook, M.N.1
Girman, C.J.2
Stein, P.P.3
-
51
-
-
0035339878
-
The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: A multicenter, randomized, double-blind, placebo-controlled trial
-
Yale J.F., Valiquett T.R., Ghazzi M.N., et al. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: A multicenter, randomized, double-blind, placebo-controlled trial. Ann Intern Med 134 (2001) 737-745
-
(2001)
Ann Intern Med
, vol.134
, pp. 737-745
-
-
Yale, J.F.1
Valiquett, T.R.2
Ghazzi, M.N.3
-
52
-
-
1242328748
-
Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double-blind trial
-
Dailey G.E., Noor M.A., Park J.-S., et al. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double-blind trial. Am J Med 116 (2004) 223-229
-
(2004)
Am J Med
, vol.116
, pp. 223-229
-
-
Dailey, G.E.1
Noor, M.A.2
Park, J.-S.3
-
53
-
-
33745000699
-
Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
-
Rosenstock J., Sugimoto D., Strange P., et al. Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care 29 (2006) 554-559
-
(2006)
Diabetes Care
, vol.29
, pp. 554-559
-
-
Rosenstock, J.1
Sugimoto, D.2
Strange, P.3
-
54
-
-
18244395527
-
A timely transition to insulin: Identifying type 2 diabetes patients failing oral therapy
-
Dailey G. A timely transition to insulin: Identifying type 2 diabetes patients failing oral therapy. Formulary 40 (2005) 114-130
-
(2005)
Formulary
, vol.40
, pp. 114-130
-
-
Dailey, G.1
-
55
-
-
3242715178
-
New strategies for basal insulin treatment in type 2 diabetes mellitus
-
Dailey G. New strategies for basal insulin treatment in type 2 diabetes mellitus. Clin Ther 26 (2004) 889-901
-
(2004)
Clin Ther
, vol.26
, pp. 889-901
-
-
Dailey, G.1
-
56
-
-
0036736185
-
When oral agents fail: Practical barriers to starting insulin
-
Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord 26 Suppl 3 (2002) S18-S24
-
(2002)
Int J Obes Relat Metab Disord
, vol.26
, Issue.SUPPL. 3
-
-
Korytkowski, M.1
-
58
-
-
0031018185
-
NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance
-
Hunt L.M., Valenzuela M.A., and Pugh J.A. NIDDM patients' fears and hopes about insulin therapy: The basis of patient reluctance. Diabetes Care 20 (1997) 292-298
-
(1997)
Diabetes Care
, vol.20
, pp. 292-298
-
-
Hunt, L.M.1
Valenzuela, M.A.2
Pugh, J.A.3
-
59
-
-
32144454714
-
Dispelling myths and removing barriers about insulin in type 2 diabetes
-
Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 32 (2006) 9S-18S
-
(2006)
Diabetes Educ
, vol.32
-
-
Meece, J.1
-
60
-
-
0030852089
-
Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
-
Shorr R.I., Ray W.A., Daugherty J.R., et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157 (1997) 1681-1686
-
(1997)
Arch Intern Med
, vol.157
, pp. 1681-1686
-
-
Shorr, R.I.1
Ray, W.A.2
Daugherty, J.R.3
-
61
-
-
0033535088
-
Drug-induced hypoglycemic coma in 102 diabetic patients
-
Ben-Ami H., Nagachandran P., Mendelson A., et al. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 159 (1999) 281-284
-
(1999)
Arch Intern Med
, vol.159
, pp. 281-284
-
-
Ben-Ami, H.1
Nagachandran, P.2
Mendelson, A.3
-
62
-
-
24944502062
-
Lower risk of hypoglycemia with insulin detemir vs NPH insulin in elderly people with type 2 diabetes: A pooled analysis of phase 3 trials
-
Garber A.J., Kim H., and Santiago O.M. Lower risk of hypoglycemia with insulin detemir vs NPH insulin in elderly people with type 2 diabetes: A pooled analysis of phase 3 trials. Diabetes 54 Suppl 1 (2005) A118
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 1
-
-
Garber, A.J.1
Kim, H.2
Santiago, O.M.3
-
63
-
-
21544436847
-
A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
-
Herman W.H., Ilag L.L., Johnson S.L., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28 (2005) 1568-1573
-
(2005)
Diabetes Care
, vol.28
, pp. 1568-1573
-
-
Herman, W.H.1
Ilag, L.L.2
Johnson, S.L.3
-
64
-
-
5044235848
-
Diabetes management in long-term care
-
Pandya N. Diabetes management in long-term care. Caring for the Ages 4 (2003) 21-24
-
(2003)
Caring for the Ages
, vol.4
, pp. 21-24
-
-
Pandya, N.1
-
65
-
-
35148880063
-
Reduced awareness of hypoglycaemia in elderly patients with type 2 diabetes
-
Schultes B., Baron M., Bremer J.P., et al. Reduced awareness of hypoglycaemia in elderly patients with type 2 diabetes. Diabetes 54 Suppl 1 (2005) A1-A733
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 1
-
-
Schultes, B.1
Baron, M.2
Bremer, J.P.3
-
66
-
-
0033661254
-
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
-
Lepore M., Pampanelli S., Fanelli C., et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49 (2000) 2142-2148
-
(2000)
Diabetes
, vol.49
, pp. 2142-2148
-
-
Lepore, M.1
Pampanelli, S.2
Fanelli, C.3
-
67
-
-
35148877702
-
-
Levemir [package insert]. Princeton, NJ: Novo Nordisk Inc, 2005.
-
-
-
-
68
-
-
35148872188
-
-
Lantus [package insert]. Kansas City: sanofi-aventis U.S. L.L.C., 2006.
-
-
-
-
69
-
-
14744306696
-
Insulin treatment in type 2 diabetes
-
Goldstein B.J., and Müller-Wieland D. (Eds), Martin Dunitz Ltd, a member of the Taylor & Francis Group, London
-
Rosenstock J., and Wyne K. Insulin treatment in type 2 diabetes. In: Goldstein B.J., and Müller-Wieland D. (Eds). Textbook of Type 2 Diabetes (2003), Martin Dunitz Ltd, a member of the Taylor & Francis Group, London 131-154
-
(2003)
Textbook of Type 2 Diabetes
, pp. 131-154
-
-
Rosenstock, J.1
Wyne, K.2
-
70
-
-
35148875564
-
-
Apidra [package insert]. Kansas City: Aventis Pharmaceuticals Inc., 2005.
-
-
-
-
71
-
-
35148871254
-
-
Humalog [package insert]. Indianapolis: Eli Lilly and Company, 2004.
-
-
-
-
72
-
-
35148876033
-
-
Novolin R [package insert]. Princeton, NJ: Novo Nordisk Inc., 2005.
-
-
-
-
73
-
-
35148901030
-
-
NovoLog [package insert]. Princeton, NJ: Novo Nordisk Inc., 2005.
-
-
-
-
74
-
-
20944432717
-
A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir
-
Plank J., Bodenlenz M., Sinner F., et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 28 (2005) 1107-1112
-
(2005)
Diabetes Care
, vol.28
, pp. 1107-1112
-
-
Plank, J.1
Bodenlenz, M.2
Sinner, F.3
-
75
-
-
33646254423
-
Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: An assessment of treatment flexibility
-
Standl E., Maxeiner S., and Raptis S. Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: An assessment of treatment flexibility. Horm Metab Res 38 (2006) 172-177
-
(2006)
Horm Metab Res
, vol.38
, pp. 172-177
-
-
Standl, E.1
Maxeiner, S.2
Raptis, S.3
-
76
-
-
0038587474
-
A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes
-
Hamann A., Matthaei S., Rosak C., et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 26 (2003) 1738-1744
-
(2003)
Diabetes Care
, vol.26
, pp. 1738-1744
-
-
Hamann, A.1
Matthaei, S.2
Rosak, C.3
-
77
-
-
0242269000
-
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
Riddle M.C., Rosenstock J., Gerich J., et al. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26 (2003) 3080-3086
-
(2003)
Diabetes Care
, vol.26
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
78
-
-
34547667494
-
Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C Study
-
Halter J.B., Kennedy L., Herman W.H., et al. Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C Study. Diabetes 55 Suppl 1 (2006) A1-A733
-
(2006)
Diabetes
, vol.55
, Issue.SUPPL. 1
-
-
Halter, J.B.1
Kennedy, L.2
Herman, W.H.3
-
79
-
-
33644873468
-
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial
-
Kennedy L., Herman W.H., Strange P., et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 29 (2006) 1-8
-
(2006)
Diabetes Care
, vol.29
, pp. 1-8
-
-
Kennedy, L.1
Herman, W.H.2
Strange, P.3
-
80
-
-
8344235966
-
The use of bolus insulin and advancing insulin therapy in type 2 diabetes
-
Karl D.M. The use of bolus insulin and advancing insulin therapy in type 2 diabetes. Curr Diab Rep 4 (2004) 352-357
-
(2004)
Curr Diab Rep
, vol.4
, pp. 352-357
-
-
Karl, D.M.1
-
81
-
-
84890634681
-
Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in elderly patients with type 2 diabetes
-
Janka H.U., Plewe G., Busch K., et al. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in elderly patients with type 2 diabetes. Diabetes 54 Suppl 1 (2005) A1-A733
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 1
-
-
Janka, H.U.1
Plewe, G.2
Busch, K.3
-
83
-
-
34147165663
-
Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004
-
Rathmann W., Haastert B., Icks A., et al. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care 30 (2007) 848-853
-
(2007)
Diabetes Care
, vol.30
, pp. 848-853
-
-
Rathmann, W.1
Haastert, B.2
Icks, A.3
-
84
-
-
34247398253
-
An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
-
Palmer A.J., Valentine W.J., Ray J.A., et al. An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK. Curr Med Res Opin 23 (2007) 895-901
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 895-901
-
-
Palmer, A.J.1
Valentine, W.J.2
Ray, J.A.3
-
85
-
-
34247366328
-
Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
-
Brändle M., Azoulay M., and Greiner R.-A. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland. Int J Clin Pharmacol Ther 45 (2007) 203-220
-
(2007)
Int J Clin Pharmacol Ther
, vol.45
, pp. 203-220
-
-
Brändle, M.1
Azoulay, M.2
Greiner, R.-A.3
-
86
-
-
25844435656
-
Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sample
-
Zhang Q., and Menditto L. Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sample. Am J Ther 12 (2005) 337-343
-
(2005)
Am J Ther
, vol.12
, pp. 337-343
-
-
Zhang, Q.1
Menditto, L.2
-
87
-
-
0642378204
-
Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus
-
Rosenblum M.S., and Kane M.P. Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus. J Manag Care Pharm 9 (2003) 309-316
-
(2003)
J Manag Care Pharm
, vol.9
, pp. 309-316
-
-
Rosenblum, M.S.1
Kane, M.P.2
-
88
-
-
16344393325
-
Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
-
Bullano M.F., Al-Zakwani I.S., Fisher M.D., et al. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products. Curr Med Res Opin 21 (2005) 291-298
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 291-298
-
-
Bullano, M.F.1
Al-Zakwani, I.S.2
Fisher, M.D.3
-
89
-
-
35148835644
-
-
Byetta [package insert]. San Diego: Amylin Pharmaceuticals, Inc., 2005.
-
-
-
-
90
-
-
16244409838
-
Exenatide: A novel incretin mimetic hormone for the treatment of type 2 diabetes
-
Gryskiewicz K.A., and Coleman C.I. Exenatide: A novel incretin mimetic hormone for the treatment of type 2 diabetes. Formulary 40 (2005) 86-90
-
(2005)
Formulary
, vol.40
, pp. 86-90
-
-
Gryskiewicz, K.A.1
Coleman, C.I.2
-
91
-
-
35148814885
-
-
Symlin injection [package insert]. San Diego: Amylin Pharmaceuticals, Inc., 2005.
-
-
-
-
92
-
-
35148868637
-
Efficacy and safety of pramlintide in insulin-using elderly patients with type 2 diabetes
-
Frias J., Lush C., Kesty N., et al. Efficacy and safety of pramlintide in insulin-using elderly patients with type 2 diabetes. Diabetes 55 Suppl 1 (2006) A1-A733
-
(2006)
Diabetes
, vol.55
, Issue.SUPPL. 1
-
-
Frias, J.1
Lush, C.2
Kesty, N.3
-
93
-
-
0042023799
-
The direct medical cost of type 2 diabetes
-
Brandle M., Zhou H., Smith B.R.K., et al. The direct medical cost of type 2 diabetes. Diabetes Care 26 (2003) 2300-2304
-
(2003)
Diabetes Care
, vol.26
, pp. 2300-2304
-
-
Brandle, M.1
Zhou, H.2
Smith, B.R.K.3
-
94
-
-
0035411216
-
A quality improvement project for better glycemic control in hospitalized patients with diabetes
-
Gilman J.A. A quality improvement project for better glycemic control in hospitalized patients with diabetes. Diabetes Educ 27 (2001) 541-546
-
(2001)
Diabetes Educ
, vol.27
, pp. 541-546
-
-
Gilman, J.A.1
|